Part of US based
Semler Group of Companies,
in business since 1946


YOU ARE HERE: Home Clinical Development Service Overview Biostatistics

SRC's experienced biostatisticians form an integral part of every clinical development program to ensure optimal statistical designs that reduce risks, accelerate timelines and reduce costs. From designing the trial to analyzing data to interpreting results, SRC's biostatisticians and programmers can improve efficiency and enable your product to optimize its market potential. Our deep understanding of the 'bio' behind the statistics underpins our approach to each deliverable.

Our comprehensive offerings include:

  • Statistical consulting for study design
  • Adaptive & Bayesian designs
  • Sample size calculation, protocol input, randomization
  • DSMBs and risk-benefit analysis
  • Statistical planning, analysis, reporting
  • SAS software programming for datasets & outputs
  • PK/PD analysis
  • Data standardization (CDISC) and integration
  • Integrated summaries of efficacy & safety



About This Service

SRC offers comprehensive Phase I-IV services for drugs, devices & diagnostics.  The team is well-entrenched in regulated market requirements & GCP. Our collective goal is to shrink your time-to-market through superior scientific expertise and trial management innovation.